Clinical Trials Browser

Recruiting × OTHER_GOV × Advanced Triple Negative Breast Cancer × Clear all

NCT05019690 2024-09-19

Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer

Phase 1/2 Recruiting

Advanced Triple Negative Breast Cancer